| ■ 영문 제목 : Global Pharmaceutical Excipients Market 2023-2027 | |
![]() | ■ 상품코드 : IRTNTR43162-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 1월 최신판(2025년 또는 2026년)은 문의주세요. ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (24시간 이내) ■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| Technavio사의 본 조사 보고서는 세계의 의약품 첨가제 시장 규모가 2023년부터 2027년 사이에 3,831.84백만 달러에 이르며, 예측 기간 중 연평균 성장률은 6.54%가 될 것으로 예상하고 있습니다. 본 보고서는 세계의 의약품 첨가제 시장에 대해 광범위한 조사를 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 종류별 (유기, 무기) 분석, 제품별 (바인더 필러, 코팅제, 붕괴제) 분석, 고객 현황, 지역별 (북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카, 영국, 미국, 독일, 캐나다, 일본) 분석, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 자료는 Actylis, Air Liquide SA, Associated British Foods Plc, Avantor Inc., BASF SE, Colorcon Inc., Croda International Plc, DFE Pharma GmbH and Co. KG, Dow Inc., Evonik Industries AG, Innophos Holdings Inc. ., J M Huber Corp., JRS PHARMA GmbH and Co. KG, Kerry Group Plc, Merck and Co. Inc., Roquette Freres SA, Wacker Chemie AG, Archer Daniels Midland Co., Ashland Inc., The Lubrizol Corp.X 등의 기업 정보를 포함하고 있습니다. ・개요 ・시장 현황 ・시장 규모 예측 ・과거 시장 규모 ・Five Force 분석 ・세계의 의약품 첨가제 시장 규모 : 종류별 - 유기 의약품 첨가제의 시장 규모 - 무기 의약품 첨가제의 시장 규모 ・세계의 의약품 첨가제 시장 규모 : 제품별 - 바인더 필러의 시장 규모 - 코팅제의 시장 규모 - 붕괴제의 시장 규모 ・고객 현황 ・세계의 의약품 첨가제 시장 규모 : 지역별 - 북미의 의약품 첨가제 시장 규모 - 유럽의 의약품 첨가제 시장 규모 - 아시아 태평양의 의약품 첨가제 시장 규모 - 남미의 의약품 첨가제 시장 규모 - 중동과 아프리카의 의약품 첨가제 시장 규모 - 영국의 의약품 첨가제 시장 규모 - 미국의 의약품 첨가제 시장 규모 - 독일의 의약품 첨가제 시장 규모 - 캐나다의 의약품 첨가제 시장 규모 - 일본의 의약품 첨가제 시장 규모 ・성장 요인/과제/동향 ・기업 현황 ・기업 분석 Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 의약품 첨가제 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 의약품 첨가제 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
글로벌 제약용 부형제 시장은 2023-2027년 동안 38억 3,184만 달러 성장할 것으로 예상되며, 이 기간 동안 연평균 성장률(CAGR)은 6.54%에 이를 것으로 보입니다. 이 보고서는 제약용 부형제 시장에 대한 포괄적인 분석을 제공하며, 시장 규모와 예측, 트렌드, 성장 요인 및 도전 과제, 그리고 약 25개 공급업체에 대한 분석을 포함하고 있습니다. 현재 시장 상황, 최신 트렌드 및 성장 동력에 대한 최신 분석을 제공합니다.
제약용 부형제 시장은 기능성 부형제에 대한 수요 증가, 제약 산업의 성장, 부형제 생산 기술의 발전이 주요 성장 동력으로 작용하고 있습니다. 시장은 유기물과 무기물로 유형이 구분되며, 제품군은 결합제 및 충전제, 코팅제, 분산제 등으로 나뉩니다. 지역별로는 북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카로 구분됩니다.
특히, 새로운 부형제에 대한 수요 증가가 쉽게 소비할 수 있는 의약품 개발을 위한 주요 요인으로 작용하며, 노화 관련 질병 및 기타 질병의 증가와 1인당 지출 증가도 시장 수요에 긍정적인 영향을 미칠 것입니다.
이 보고서는 제약용 부형제 시장의 규모, 예측, 산업 분석을 포함하고 있으며, 공급업체 분석을 통해 고객이 시장 내 위치를 개선할 수 있도록 돕습니다. 주요 공급업체로는 Actylis, Air Liquide SA, Associated British Foods Plc, Avantor Inc., BASF SE, Colorcon Inc., Croda International Plc, DFE Pharma GmbH, Dow Inc., Evonik Industries AG, Innophos Holdings Inc., J M Huber Corp., JRS PHARMA GmbH, Kerry Group Plc, Merck and Co. Inc., Roquette Freres SA, Wacker Chemie AG, Archer Daniels Midland Co., Ashland Inc., The Lubrizol Corp. 등이 있습니다. 또한, 제약용 부형제 시장 분석 보고서는 향후 시장 성장에 영향을 미칠 트렌드와 도전 과제에 대한 정보도 포함되어 있어 기업들이 향후 성장 기회를 전략적으로 활용할 수 있도록 돕습니다.
이 연구는 주요 산업 참여자의 입력을 포함한 1차 및 2차 정보를 조합하여 객관적으로 수행되었습니다. 보고서는 포괄적인 시장 및 공급업체 환경을 포함하고 있으며 주요 공급업체에 대한 분석도 제공합니다. Technavio는 수익, 가격, 경쟁 및 프로모션과 같은 주요 매개변수 분석을 통해 시장의 다양한 측면을 제시하고 있으며, 주요 산업 영향력을 식별하여 신뢰할 수 있는 데이터를 제공합니다.
■ 보고서 목차• 1 요약 • 3 시장 규모 o 표 38: 무기적 성장 – 시장 규모 및 전망 차트 2022-2027 (백만 달러) o 표 51: 코팅제 차트 – 2022-2027년 시장 규모 및 전망(백만 달러) • 12 공급업체 분석 o 표 168: Roquette Freres SA – 제품/서비스 o 표 175: Wacker Chemie AG – 주요 제공 서비스 첨부 자료: 표 1: 요약 – 시장 개요 차트 첨부자료 17: 글로벌 시장: 전년 대비 성장률 2022-2027 (%) 데이터 표 첨부자료 18: 과거 시장 규모 데이터 2017년~2021년 세계 제약 부형제 시장 현황표 (백만 달러) 표 44: 제품별 시장 점유율 데이터표 2022-2027 (%) 표 60: 기타 시장 규모 및 전망(2022-2027년, 백만 달러) 데이터 표 표 88: 중동 및 아프리카 데이터 표 – 2022-2027년 전년 대비 성장률(%) 표 96: 미국 시장 데이터표 – 2022-2027년 전년 대비 성장률(%) 표 104: 캐나다 데이터 표 – 2022-2027년 전년 대비 성장률(%) 첨부자료 155: 에보닉 인더스트리즈 AG – 사업 부문 o 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global pharmaceutical excipients market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on Global pharmaceutical excipients market 2017 - 2021 ($ million) o 4.2 Type Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million) o 4.3 Product Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Type o 6.1 Market segments o Exhibit 30: Chart on Type - Market share 2022-2027 (%) o Exhibit 31: Data Table on Type - Market share 2022-2027 (%) o 6.2 Comparison by Type o Exhibit 32: Chart on Comparison by Type o Exhibit 33: Data Table on Comparison by Type o 6.3 Organic - Market size and forecast 2022-2027 o Exhibit 34: Chart on Organic - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Organic - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Organic - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Organic - Year-over-year growth 2022-2027 (%) o 6.4 Inorganic - Market size and forecast 2022-2027 o Exhibit 38: Chart on Inorganic - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Inorganic - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Inorganic - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Inorganic - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Type o Exhibit 42: Market opportunity by Type ($ million) • 7 Market Segmentation by Product o 7.1 Market segments o Exhibit 43: Chart on Product - Market share 2022-2027 (%) o Exhibit 44: Data Table on Product - Market share 2022-2027 (%) o 7.2 Comparison by Product o Exhibit 45: Chart on Comparison by Product o Exhibit 46: Data Table on Comparison by Product o 7.3 Binders and fillers - Market size and forecast 2022-2027 o Exhibit 47: Chart on Binders and fillers - Market size and forecast 2022-2027 ($ million) o Exhibit 48: Data Table on Binders and fillers - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Chart on Binders and fillers - Year-over-year growth 2022-2027 (%) o Exhibit 50: Data Table on Binders and fillers - Year-over-year growth 2022-2027 (%) o 7.4 Coating agents - Market size and forecast 2022-2027 o Exhibit 51: Chart on Coating agents - Market size and forecast 2022-2027 ($ million) o Exhibit 52: Data Table on Coating agents - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Chart on Coating agents - Year-over-year growth 2022-2027 (%) o Exhibit 54: Data Table on Coating agents - Year-over-year growth 2022-2027 (%) o 7.5 Disintegrants - Market size and forecast 2022-2027 o Exhibit 55: Chart on Disintegrants - Market size and forecast 2022-2027 ($ million) o Exhibit 56: Data Table on Disintegrants - Market size and forecast 2022-2027 ($ million) o Exhibit 57: Chart on Disintegrants - Year-over-year growth 2022-2027 (%) o Exhibit 58: Data Table on Disintegrants - Year-over-year growth 2022-2027 (%) o 7.6 Others - Market size and forecast 2022-2027 o Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million) o Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million) o Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%) o Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%) o 7.7 Market opportunity by Product o Exhibit 63: Market opportunity by Product ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%) o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 67: Chart on Geographic comparison o Exhibit 68: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 APAC - Market size and forecast 2022-2027 o Exhibit 77: Chart on APAC - Market size and forecast 2022-2027 ($ million) o Exhibit 78: Data Table on APAC - Market size and forecast 2022-2027 ($ million) o Exhibit 79: Chart on APAC - Year-over-year growth 2022-2027 (%) o Exhibit 80: Data Table on APAC - Year-over-year growth 2022-2027 (%) o 9.6 South America - Market size and forecast 2022-2027 o Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million) o Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million) o Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%) o Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%) o 9.7 Middle East and Africa - Market size and forecast 2022-2027 o Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million) o Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million) o Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%) o Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%) o 9.8 UK - Market size and forecast 2022-2027 o Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.9 US - Market size and forecast 2022-2027 o Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.10 Germany - Market size and forecast 2022-2027 o Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.11 Canada - Market size and forecast 2022-2027 o Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%) o Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%) o 9.12 Japan - Market size and forecast 2022-2027 o Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.13 Market opportunity By Geographical Landscape o Exhibit 109: Market opportunity By Geographical Landscape ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 110: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 112: Overview on factors of disruption o 11.4 Industry risks o Exhibit 113: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 114: Vendors covered o 12.2 Market positioning of vendors o Exhibit 115: Matrix on vendor position and classification o 12.3 Archer Daniels Midland Co. o Exhibit 116: Archer Daniels Midland Co. - Overview o Exhibit 117: Archer Daniels Midland Co. - Business segments o Exhibit 118: Archer Daniels Midland Co. - Key offerings o Exhibit 119: Archer Daniels Midland Co. - Segment focus o 12.4 Ashland Inc. o Exhibit 120: Ashland Inc. - Overview o Exhibit 121: Ashland Inc. - Business segments o Exhibit 122: Ashland Inc. - Key news o Exhibit 123: Ashland Inc. - Key offerings o Exhibit 124: Ashland Inc. - Segment focus o 12.5 Associated British Foods Plc o Exhibit 125: Associated British Foods Plc - Overview o Exhibit 126: Associated British Foods Plc - Business segments o Exhibit 127: Associated British Foods Plc - Key offerings o Exhibit 128: Associated British Foods Plc - Segment focus o 12.6 Avantor Inc. o Exhibit 129: Avantor Inc. - Overview o Exhibit 130: Avantor Inc. - Business segments o Exhibit 131: Avantor Inc. - Key offerings o Exhibit 132: Avantor Inc. - Segment focus o 12.7 BASF SE o Exhibit 133: BASF SE - Overview o Exhibit 134: BASF SE - Business segments o Exhibit 135: BASF SE - Key news o Exhibit 136: BASF SE - Key offerings o Exhibit 137: BASF SE - Segment focus o 12.8 Colorcon Inc. o Exhibit 138: Colorcon Inc. - Overview o Exhibit 139: Colorcon Inc. - Product / Service o Exhibit 140: Colorcon Inc. - Key offerings o 12.9 Croda International Plc o Exhibit 141: Croda International Plc - Overview o Exhibit 142: Croda International Plc - Business segments o Exhibit 143: Croda International Plc - Key news o Exhibit 144: Croda International Plc - Key offerings o Exhibit 145: Croda International Plc - Segment focus o 12.10 DFE Pharma GmbH and Co. KG o Exhibit 146: DFE Pharma GmbH and Co. KG - Overview o Exhibit 147: DFE Pharma GmbH and Co. KG - Product / Service o Exhibit 148: DFE Pharma GmbH and Co. KG - Key offerings o 12.11 Dow Inc. o Exhibit 149: Dow Inc. - Overview o Exhibit 150: Dow Inc. - Business segments o Exhibit 151: Dow Inc. - Key news o Exhibit 152: Dow Inc. - Key offerings o Exhibit 153: Dow Inc. - Segment focus o 12.12 Evonik Industries AG o Exhibit 154: Evonik Industries AG - Overview o Exhibit 155: Evonik Industries AG - Business segments o Exhibit 156: Evonik Industries AG - Key news o Exhibit 157: Evonik Industries AG - Key offerings o Exhibit 158: Evonik Industries AG - Segment focus o 12.13 Innophos Holdings Inc. o Exhibit 159: Innophos Holdings Inc. - Overview o Exhibit 160: Innophos Holdings Inc. - Product / Service o Exhibit 161: Innophos Holdings Inc. - Key offerings o 12.14 Merck and Co. Inc. o Exhibit 162: Merck and Co. Inc. - Overview o Exhibit 163: Merck and Co. Inc. - Business segments o Exhibit 164: Merck and Co. Inc. - Key news o Exhibit 165: Merck and Co. Inc. - Key offerings o Exhibit 166: Merck and Co. Inc. - Segment focus o 12.15 Roquette Freres SA o Exhibit 167: Roquette Freres SA - Overview o Exhibit 168: Roquette Freres SA - Product / Service o Exhibit 169: Roquette Freres SA - Key offerings o 12.16 The Lubrizol Corp. o Exhibit 170: The Lubrizol Corp. - Overview o Exhibit 171: The Lubrizol Corp. - Product / Service o Exhibit 172: The Lubrizol Corp. - Key offerings o 12.17 Wacker Chemie AG o Exhibit 173: Wacker Chemie AG - Overview o Exhibit 174: Wacker Chemie AG - Business segments o Exhibit 175: Wacker Chemie AG - Key offerings o Exhibit 176: Wacker Chemie AG - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 177: Inclusions checklist o Exhibit 178: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 179: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 180: Research methodology o Exhibit 181: Validation techniques employed for market sizing o Exhibit 182: Information sources o 13.5 List of abbreviations o Exhibit 183: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Type Exhibits6: Executive Summary - Chart on Market Segmentation by Product Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on Global pharmaceutical excipients market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Type - Market share 2022-2027 (%) Exhibits31: Data Table on Type - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Type Exhibits33: Data Table on Comparison by Type Exhibits34: Chart on Organic - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Organic - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Organic - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Organic - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Inorganic - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Inorganic - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Inorganic - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Inorganic - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Type ($ million) Exhibits43: Chart on Product - Market share 2022-2027 (%) Exhibits44: Data Table on Product - Market share 2022-2027 (%) Exhibits45: Chart on Comparison by Product Exhibits46: Data Table on Comparison by Product Exhibits47: Chart on Binders and fillers - Market size and forecast 2022-2027 ($ million) Exhibits48: Data Table on Binders and fillers - Market size and forecast 2022-2027 ($ million) Exhibits49: Chart on Binders and fillers - Year-over-year growth 2022-2027 (%) Exhibits50: Data Table on Binders and fillers - Year-over-year growth 2022-2027 (%) Exhibits51: Chart on Coating agents - Market size and forecast 2022-2027 ($ million) Exhibits52: Data Table on Coating agents - Market size and forecast 2022-2027 ($ million) Exhibits53: Chart on Coating agents - Year-over-year growth 2022-2027 (%) Exhibits54: Data Table on Coating agents - Year-over-year growth 2022-2027 (%) Exhibits55: Chart on Disintegrants - Market size and forecast 2022-2027 ($ million) Exhibits56: Data Table on Disintegrants - Market size and forecast 2022-2027 ($ million) Exhibits57: Chart on Disintegrants - Year-over-year growth 2022-2027 (%) Exhibits58: Data Table on Disintegrants - Year-over-year growth 2022-2027 (%) Exhibits59: Chart on Others - Market size and forecast 2022-2027 ($ million) Exhibits60: Data Table on Others - Market size and forecast 2022-2027 ($ million) Exhibits61: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibits62: Data Table on Others - Year-over-year growth 2022-2027 (%) Exhibits63: Market opportunity by Product ($ million) Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%) Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%) Exhibits67: Chart on Geographic comparison Exhibits68: Data Table on Geographic comparison Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits77: Chart on APAC - Market size and forecast 2022-2027 ($ million) Exhibits78: Data Table on APAC - Market size and forecast 2022-2027 ($ million) Exhibits79: Chart on APAC - Year-over-year growth 2022-2027 (%) Exhibits80: Data Table on APAC - Year-over-year growth 2022-2027 (%) Exhibits81: Chart on South America - Market size and forecast 2022-2027 ($ million) Exhibits82: Data Table on South America - Market size and forecast 2022-2027 ($ million) Exhibits83: Chart on South America - Year-over-year growth 2022-2027 (%) Exhibits84: Data Table on South America - Year-over-year growth 2022-2027 (%) Exhibits85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million) Exhibits86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million) Exhibits87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%) Exhibits88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%) Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%) Exhibits105: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits106: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits107: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits108: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits109: Market opportunity By Geographical Landscape ($ million) Exhibits110: Impact of drivers and challenges in 2022 and 2027 Exhibits111: Overview on Criticality of inputs and Factors of differentiation Exhibits112: Overview on factors of disruption Exhibits113: Impact of key risks on business Exhibits114: Vendors covered Exhibits115: Matrix on vendor position and classification Exhibits116: Archer Daniels Midland Co. - Overview Exhibits117: Archer Daniels Midland Co. - Business segments Exhibits118: Archer Daniels Midland Co. - Key offerings Exhibits119: Archer Daniels Midland Co. - Segment focus Exhibits120: Ashland Inc. - Overview Exhibits121: Ashland Inc. - Business segments Exhibits122: Ashland Inc. - Key news Exhibits123: Ashland Inc. - Key offerings Exhibits124: Ashland Inc. - Segment focus Exhibits125: Associated British Foods Plc - Overview Exhibits126: Associated British Foods Plc - Business segments Exhibits127: Associated British Foods Plc - Key offerings Exhibits128: Associated British Foods Plc - Segment focus Exhibits129: Avantor Inc. - Overview Exhibits130: Avantor Inc. - Business segments Exhibits131: Avantor Inc. - Key offerings Exhibits132: Avantor Inc. - Segment focus Exhibits133: BASF SE - Overview Exhibits134: BASF SE - Business segments Exhibits135: BASF SE - Key news Exhibits136: BASF SE - Key offerings Exhibits137: BASF SE - Segment focus Exhibits138: Colorcon Inc. - Overview Exhibits139: Colorcon Inc. - Product / Service Exhibits140: Colorcon Inc. - Key offerings Exhibits141: Croda International Plc - Overview Exhibits142: Croda International Plc - Business segments Exhibits143: Croda International Plc - Key news Exhibits144: Croda International Plc - Key offerings Exhibits145: Croda International Plc - Segment focus Exhibits146: DFE Pharma GmbH and Co. KG - Overview Exhibits147: DFE Pharma GmbH and Co. KG - Product / Service Exhibits148: DFE Pharma GmbH and Co. KG - Key offerings Exhibits149: Dow Inc. - Overview Exhibits150: Dow Inc. - Business segments Exhibits151: Dow Inc. - Key news Exhibits152: Dow Inc. - Key offerings Exhibits153: Dow Inc. - Segment focus Exhibits154: Evonik Industries AG - Overview Exhibits155: Evonik Industries AG - Business segments Exhibits156: Evonik Industries AG - Key news Exhibits157: Evonik Industries AG - Key offerings Exhibits158: Evonik Industries AG - Segment focus Exhibits159: Innophos Holdings Inc. - Overview Exhibits160: Innophos Holdings Inc. - Product / Service Exhibits161: Innophos Holdings Inc. - Key offerings Exhibits162: Merck and Co. Inc. - Overview Exhibits163: Merck and Co. Inc. - Business segments Exhibits164: Merck and Co. Inc. - Key news Exhibits165: Merck and Co. Inc. - Key offerings Exhibits166: Merck and Co. Inc. - Segment focus Exhibits167: Roquette Freres SA - Overview Exhibits168: Roquette Freres SA - Product / Service Exhibits169: Roquette Freres SA - Key offerings Exhibits170: The Lubrizol Corp. - Overview Exhibits171: The Lubrizol Corp. - Product / Service Exhibits172: The Lubrizol Corp. - Key offerings Exhibits173: Wacker Chemie AG - Overview Exhibits174: Wacker Chemie AG - Business segments Exhibits175: Wacker Chemie AG - Key offerings Exhibits176: Wacker Chemie AG - Segment focus Exhibits177: Inclusions checklist Exhibits178: Exclusions checklist Exhibits179: Currency conversion rates for US$ Exhibits180: Research methodology Exhibits181: Validation techniques employed for market sizing Exhibits182: Information sources Exhibits183: List of abbreviations |
| ※참고 정보 의약품 첨가제(Pharmaceutical Excipients)는 의약품 제형에서 활성 성분과 함께 사용되는 비활성 성분으로, 약물의 약리 작용에는 영향을 미치지 않지만, 약물의 제조, 저장, 및 사용성을 개선하는 역할을 한다. 첨가제는 약물의 물리적, 화학적 성질을 조절하고, 액체, 고체, 또는 기체 형태로의 제형을 가능하게 하며, 체내에서의 약물 방출 및 흡수를 조절하는 데 기여한다. 이러한 첨가제는 매우 다양한 기능을 가지고 있으며, 약물의 효과적인 전달과 환자의 안전성을 보장하는 데 필수적이다. 의약품 첨가제는 주로 다음과 같은 종류로 나눌 수 있다. 첫째, 부형제는 활성 성분의 체적을 늘리거나, 제형의 경도를 개선하는 데 사용된다. 둘째, 바인더는 분말 상태의 성분들이 잘 뭉쳐지도록 도와주며, 정제화 과정에서 중요한 역할을 한다. 셋째, 윤활제는 정제의 생산 과정에서 마찰을 줄이고, 정제의 분리 및 제조 공정을 용이하게 도와준다. 넷째, 방부제는 의약품의 변질을 방지하고 유통 기한을 늘리는 역할을 한다. 마지막으로, 맛 개선제나 착향제는 환자가 약물을 보다 쉽게 복용할 수 있도록 돕는다. 이 외에도 다양한 종류의 첨가제가 있으며, 각각의 용도와 기능은 다르다. 예를 들어, 재료의 용해도를 높이는 용해 보조제는 액체 제형에서 주로 사용되며, 흡수 촉진제는 장내 흡수를 증가시켜 약효 발현 속도를 높이는 데 기여한다. 이러한 첨가제들은 제형의 안정성을 확보하고, 약물의 생체이용률을 향상시키기 위해 매우 중요하다. 최근에는 새로운 기술들의 발전으로 의약품 첨가제의 설계 및 제조 방식이 변화하고 있다. 나노기술을 활용한 분자 수준의 첨가제 개발이 주목받고 있으며, 이는 약물의 방출 프로필을 정밀하게 조절할 수 있는 가능성을 열어준다. 또한, 개인 맞춤형 의약품의 필요성이 커짐에 따라 특정 환자군에 적합한 첨가제를 개발하는 연구도 활발히 진행되고 있다. 의약품 첨가제는 의약품의 안전성과 효과성을 높이는 등 중요한 역할을 하기에 관련 규제와 안전성 평가가 필수적이다. 여러 국가에서는 의약품 첨가제에 대한 엄격한 기준을 마련하여, 오염 가능성이나 부작용을 최소화하기 위한 조치를 취하고 있다. 이는 환자의 건강을 최우선으로 고려하는 의약품 개발에 있어 필수적인 과정이며, 새로운 첨가제를 임상에 도입하기 위해서는 충분한 연구와 데이터를 바탕으로 한 철저한 검토가 이루어져야 한다. 따라서 의약품 첨가제는 의약품 생산 공정에서 필수적인 요소로 자리잡고 있으며, 제약 산업의 발전과 함께 그 필요성과 중요성이 더욱 강조되고 있다. 앞으로도 첨가제의 연구 및 개발은 더욱 활성화될 것으로 기대되며, 이를 통해 더욱 안전하고 효과적인 의약품이 환자에게 제공될 수 있을 것이다. |
| ※본 조사보고서 [세계의 의약품 첨가제 시장 (2023년~2027년)] (코드 : IRTNTR43162-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 의약품 첨가제 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |

